Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Farmers Insurance
US Army
US Department of Justice
Cerilliant
Fuji
Medtronic
Federal Trade Commission

Generated: July 18, 2018

DrugPatentWatch Database Preview

Bazedoxifene acetate; estrogens, conjugated - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for bazedoxifene acetate; estrogens, conjugated and what is the scope of bazedoxifene acetate; estrogens, conjugated patent protection?

Bazedoxifene acetate; estrogens, conjugated
is the generic ingredient in one branded drug marketed by Wyeth Pharms Pfizer and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Bazedoxifene acetate; estrogens, conjugated has sixty-four patent family members in forty countries.

There are three drug master file entries for bazedoxifene acetate; estrogens, conjugated. Two suppliers are listed for this compound.
Summary for bazedoxifene acetate; estrogens, conjugated
International Patents:64
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Suppliers / Packagers: 2
Clinical Trials: 4
DailyMed Link:bazedoxifene acetate; estrogens, conjugated at DailyMed
Pharmacology for bazedoxifene acetate; estrogens, conjugated

US Patents and Regulatory Information for bazedoxifene acetate; estrogens, conjugated

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for bazedoxifene acetate; estrogens, conjugated

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,127,404 Tissue selective compounds in the treatment of endometrial proliferation ➤ Try a Free Trial
6,225,308 Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy ➤ Try a Free Trial
6,232,307 Tissue selective compounds in the treatment of ovarian cancer ➤ Try a Free Trial
6,291,451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for bazedoxifene acetate; estrogens, conjugated

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
09/028 Ireland ➤ Try a Free Trial PRODUCT NAME: BAZEDOXIFENE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/09/511/001-004 20090417
608 Luxembourg ➤ Try a Free Trial 91608, EXPIRES: 20220415
2009 00035 Denmark ➤ Try a Free Trial
0416 Netherlands ➤ Try a Free Trial 300416, 20170415, EXPIRES: 20220414
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
Fuji
Cantor Fitzgerald
US Department of Justice
Chinese Patent Office
Argus Health
Dow
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.